[1] Guidelines for the prevention,care and treatment of persons with chronic heptitis B infection[J]. WHO, 2015. [2] Wang FS, Fan JG, Zhang Z, et al. The global burden of liver disease:the major impact of China[J]. Hepatology, 2014, 60(6):2099-2108. [3] 齐小秋,王宇. 全国人群乙型病毒性肝炎血清流行病学调查报告[M]. 北京:人民卫生出版社,2011:46-48. [4] Tong SP, Li JS, Wands JR, et al. Hepatitis B virus genetic variants:biological propertiesand clinical implications[J]. Emerg Microbes Infect, 2013, 2(1):1-11. [5] 杨绍基. 传染病学[M]. 北京:人民卫生出版社, 2005:20. [6] Kao JH, Chen DS. Global control of hepatitis B virus infection[J].Lancet Infect Dis, 2002, 2(7):395-403. [7] Pourkarim MP, Amini-Bavil-Olyaee S, Kurbanov F, et al. Molecular identification of hepatitis B virus genotypes/subgenotypes:revised classification hurdles and updated resolutions[J]. World J Gastroenterol, 2014, 20(23):7152-7168. [8] Shi W, Zhang Z, Ling C, et al. Hepatitis B virus subgenotyping:history, effects of recombination, misclassifications, and corrections[J]. InfectGenet Evol, 2013, 16:355-3561. [9] Mahtab MA, Rahman S, Khan M, et al. Hepatitis B virus genotypes: an overview[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(5):457-464. [10] Panduro A, Maldonado M, Fierro NA, et al. Distribution of HBV genotypes F and H in Mexico and Central America[J]. Antivir Ther, 2013, 18(3 Pt B):475-484. [11] Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances[J]. J Gastroen Hepatol, 2011, 26(Suppl 1):123-130. [12] Sunbul M. Hepatitis B virus genotypes:global distribution and clinical importance[J]. World J Gastroenterol, 2014, 20(18):5427-5434. [13] Kramvis A. Genotypes and genetic variability of hepatitis B virus[J]. Intervirology, 2014, 57(3-4):141-150. [14] Tran TT, Trinh TN, Abe K. New complex recombinant genotype of hepatitis B virus identified in Vietnam[J]. J Virol, 2008, 82(11):5657-5663. [15] Tatematsu K, Tanaka Y, Kurbanov F, et al. A genetic variant of hepatitis B virus divergent from known human and Ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J[J]. J Virol, 2009, 83(20):10538-10547. [16] Yuan J, Zhou B, Tanaka Y, et al. Hepatitis B virus (HBV) genotypes/subgenotypes in China:mutations in core promoter and precore/core and their clinical implications[J]. J Clin Virol, 2007, 39(2):87-93. [17] Li HM, Wang JQ, Wang R, et al. Hepatitis B virus genotypes and genome characteristics in China[J]. World J Gastroenterol, 2015, 21(21):6684-6697. [18] Guirgis BS, Abbas RO, Azzazy HM. Hepatitis B virus genotyping:current methods and clinical implications[J]. Int J Infect Dis, 2010, 14(11):e941-953. [19] Tamada Y, Yatsuhashi H, Masaki N, et al. Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B[J]. Gut, 2012, 61(5):765-773. [20] 刘兴,唐红,何芳. 乙型肝炎病毒基因型研究新进展[J]. 世界华人消化杂志, 2006, 14(22):2211-2216. [21] 闫涛. HBV基因组与变异[J]. 肝脏, 2010, 15(2):127-130. [22] Bartholomeusz A, Schaefer S. Hepatitis B virus genotypes:comparison of genotyping methods[J]. Rev Med Virol, 2004, 14(1):3-16. [23] Du H, Li T, Zhang HY, et al. Correlation of hepatitis B virus (HBV) genotypes and mutations in basal core promoter/precore with clinical features of chronic HBV infection[J]. Liver Int, 2007, 27(2):240-246. [24] Sharma S, Sharma B, Singla B, et al. Clinical significance of genotypes and precore/basal core promoter mutations in HBV related chronic liver disease patients in North India[J]. Digest Dis Sci,2010, 55(3):794-802.[25] Erhardt A, Gobel T, Ludwig A, et al. Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H[J]. J Med Virol, 2009, 81(10):1716-1720. [26] Kato H, Orito E, Gish RG, et al. Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes (A through F)[J]. J Virol, 2002, 76(12):6131-6137. [27] Kao JH, Wu NH, Chen PJ, et al. Hepatitis B genotypes and the response to interferon therapy[J].J Hepatol, 2000,31:998-1002. [28] 耿颖,张建军. 乙型肝炎病毒基因变异与临床[J]. 医学综述, 2008, 14(4):544-546. [29] 钱福初,秦基取,杨水新. 慢性乙型肝炎病毒感染者乙型肝炎病毒S基因变异分析[J]. 中华医院感染学杂志, 2011, 21(8):1514-1516. [30] 中华医学会肝病学分会 . 慢性乙型肝炎防治指南[J]. 实用肝脏病杂志, 2011, 14(2):81-89. [31] Wu F, Wu MJ, Zhuge XL, et al. Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment[J]. HBPD Int, 2012, 11(2):172-176. [32] Li X, Liu Y, Xu Z, et al. A complete genomic analysis of hepatitis B virus isolated from 516 Chinese patients with different clinical manifestations[J]. J Med Virol, 2013, 85(10):1698-1704. [33] Liaw YF, Kao JH, Piratvisuth T, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B:a 2012 update[J].Hepatol Int, 2012, 6(3):531-561. [34] Lin CL, Kao JH. Hepatitis B virus genotypes and variants[J]. CSH Perspect Med, 2015, 5(5):a021436. [35] Sanchez-Tapias JM, Costa J, Mas A, et al. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients[J]. Gastroenterology, 2002, 123(6):1848-1856. [36] Kao JH, Chen PJ, Lai MY. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B[J]. Gastroenterology, 2000, 118(3):554-559. [37] Chen CH, Hung CH, Lee CM, et al. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients[J]. Gastroenterology, 2007, 133(5):1466-1474. [38] Livingston SE, Simonetti P, McMahon BJ, et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F[J]. J Infect Dis, 2007,195(1):5-11. [39] Wai CT, Chu CJ, Hussain M, et al. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C[J]. Hepatology,2002, 36(6):1425-1430. [40] Erhardt A, Blondin D, Hauck K, et al. Response to interferon alfa is hepatitis B virus genotype dependent:genotype A is more sensitive to interferon than genotype D[J]. Gut, 2005, 54(7):1009-1013. [41] 王元海,周琼. 聚乙二醇化干扰素α-2a对乙肝病毒复制以及慢性乙型肝炎患者抗原指标转阴的影响[J]. 实用预防医学, 2012, 19(5):735-737. [42] Janssen HL, van Zonneveld M, Senturk H, et al. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B:a randomised trial[J]. Lancet, 2005, 365(9454):123-129. [43] Wiegand J,Hasenclever D, Tillmann HL. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence[J]. Antiv Ther, 2008, 13(2):211-220.
2017, Vol. 24 
